Neuropsychopharmacology
Journal of Psychopharmacology
European Neuropsychopharmacology
Psychopharmacology
- Evaluation of tradipitant, a selective NK1 antagonist, on response to oxycodone in humans4 years ago
- Acute intranasal dopamine application counteracts the reversal learning deficit of spontaneously hypertensive rats in an attentional set-shifting task4 years ago
- Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial4 years ago
- Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers4 years ago
- The selective 5-HT 1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress4 years ago
- The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study4 years ago
- Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty214 years ago
International Journal of Neuropsychopharmacology
Frontiers in Pharmacology
Translational Psychiatry
Molecular Psychiatry
Nature Reviews Neuroscience
CNS Spectrum
Neuropharmacology
Nature
- How Europe aims to woo US scientists and protect academic freedom5 months ago
- CERN releases detailed plans for supercollider — but no hints about funding5 months ago
- Author Correction: Isoprene nitrates drive new particle formation in Amazon’s upper troposphere5 months ago
- ‘One of the darkest days’: NIH purges agency leadership amid mass layoffs5 months ago
- El Niños that linger are becoming less of a rarity5 months ago
- Daily briefing: Mass layoffs across US health agencies5 months ago
- China has already taken steps to reduce retractions of papers from its hospitals5 months ago